Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Nov 1;102(9):1704-14.
doi: 10.1172/JCI4160.

GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice

Affiliations

GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice

M R Stämpfli et al. J Clin Invest. .

Abstract

The purpose of this study was to explore whether repeated exposure to aerosolized ovalbumin (OVA) in the context of local expression of GM-CSF can initiate a Th2-driven, eosinophilic inflammation in the airways. On day -1, Balb/c mice were infected intranasally with an adenovirus construct expressing GM-CSF (Ad/GM-CSF). From day 0 to day 9 mice were exposed daily to an OVA aerosol. Mice exposed to OVA alone did not show any evidence of airway inflammation. Mice receiving both Ad/GM-CSF and aerosolized OVA exhibited marked airway inflammation characterized by eosinophilia and goblet cell hyperplasia. Migration of eosinophils into the airway was preceded by a rise in IL-5 and IL-4. Both IL-5 and class II MHC were critically required to generate airway eosinophilia. After resolution, airway eosinophilia was reconstituted after a single OVA exposure. Flow cytometric analysis of dispersed lung cells revealed an increase in macrophages and dendritic cells expressing B7.1 and B7.2, and expansion of activated (CD69-expressing) CD4 and CD8 T cells in mice exposed to OVA and Ad/GM-CSF. Our data indicate that expression of GM-CSF in the airway compartment increases local antigen presentation capacity, and concomitantly facilitates the development of an antigen-specific, eosinophilic inflammatory response to an otherwise innocuous antigen.

PubMed Disclaimer

References

    1. J Immunol. 1997 Jul 15;159(2):565-73 - PubMed
    1. Am J Respir Cell Mol Biol. 1997 May;16(5):510-20 - PubMed
    1. J Immunol. 1997 Sep 15;159(6):3009-15 - PubMed
    1. Clin Exp Immunol. 1998 Aug;113(2):157-65 - PubMed
    1. N Engl J Med. 1992 Jan 30;326(5):298-304 - PubMed

Publication types

MeSH terms